Although further studies in breast cancer cells are needed to identify up-stream and down-stream NGB regulating pathways and the intracellular NGB trafficking, present data might lead to a new direction in understanding NGB function cancer and neuroprotection opening new avenues for the therapeutic intervention based on the development of inhibitors impairing NGB-dependent cell protection. Here, NGB is linked to breast carcinoma.